Clinical Trial Update: A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2599666 in healthy participants and individuals with mild cognitive impairment or Alzheimer's disease; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Healthy

Drugs mentioned

• LY2599666

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Alzheimer's Disease | Phase 1 | Status: TERMINATED | Results posted: 2019-09-23